drugs. 1, 4, 5 In Bangladesh a few studies have been done on this topic which show radioiodine therapy is an effective means of treatment, although those are not still sufficient to cover the topic in our country. We have done this study in Khulna medical college hospital from January 2002 to January 2003. It was undertaken to find out the effectiveness of radio-iodine therapy in controlling hyperthyroidism & to observe the short term outcome of radio-iodine treatment.
Materials and Methods:
Fifty cases of hyperthyroidism diagnosed by usual clinical and biochemical criteria including raised T 3 , T4 & suppressed TSH from Khulna Medical College Hospital (KMCH) and Centre for Nuclear Medicine & Ultrasound, Khulna, were selected for the study. Radio nuclide scan was performed in all cases, post therapy follow up was done at 3 months, 6 months, 9 months, 1 year. Clinical & biochemical evaluation was assessed in each follow up visit. Serum T 3 and T 4 was measured by radioimmunoassay technique and TSH by immuno radiometric assay technique.
Elderly patients and all those with cardiac disease and severe hyperthyroidism were pretreated with a short course of antithyroid drugs in full dosages until they were clinically and biochemically euthyroid. Antithyroid drugs were stopped 3 days before radioiodine administration. No patient had posttreatment antithyroid drugs during follow-up period. Before administering radioiodine, the nature of treatment, the importance of precautionary measures and follow-up necessity was explained to the patients.
Results:
Out of fifty patients the maximum age was 75 years and the minimum age 17 years. The mean age was 39.87 years. Of these patients (Table I) females were more sufferer 28 (56%) than the male 22 (44%). Male (22) and female (28) ration was 1:1.2 The highest number of patient belongs to 30-34 and 40-44 age groups and least number belongs to 20-24 age group (Fig 1) . No. of female patients 28 56
Out of 50 patients 38 (76%) were found to have defuse toxic goitre, 5(10%) solitary toxic nodule, 1(2%) multinodular toxic goitre, 4(8%) impalpable gland with thyrotoxicosis and 2(4%) with relapsing thyrotoxicosis received oral radioiodine therapy (Table II) . On follow up 5 patients lost after first follow up at 3 months. Of the 45 patients 27(60%) were euthyroid, 16(35.6%) became hypothyroid and replacement therapy by thyroxin were started, 2(4.4%) remaining hyperthyroid and they were treated by second dose of radioiodine therapy. Of 16 patients who became hypothyroid after getting radioiodine therapy, 5 patients become hypothyroid within three months, 3 patients within 6 months, 6 patients within 9 months and 2 patients within 1 year (Table IV) . No adverse effect of radioiodine drink was observed. After follow up 27(60%) patients become euthyroid, 16(35.6%) patients become hypothyroid and 2(4.4%) patients remained as hyperthyroid (Table V) . In this series our purpose was to evaluate the effectiveness of radioiodine controlling hyperthyroidism and the short term outcome of radioiodine treatment. All patients were enrolled for radioiodine therapy. Follow up was done at 3 monthly for the 1 st year.
Clinical & biochemical evaluation of thyroid functions was assessed in each follow-up visit. Of these 50 cases, 38(76%) patients of diffuse toxic goitre, 5(10%) patients of impalpable glands with thyrotoxicosis and 2(4%) relapsing thyroxicosis received radioiodine therapy.
(34%) patients with higher hormone level or other medical complication like cardiovascular problems were pretreated with antithyroid drugs. The drug was discontinued 3 days before receiving radioiodine therapy. Rest of the patients received either no treatment or beta-blocker drug prior to radioiodine therapy. In this current series about 60% become euthyroid which is a better result in comparison to other study done by Sankar et al in India. 9 Hypothyroidism is an inevitable consequence of the treatment of hyperthyroidism with radioactive iodine and almost certainly would occur in all patients if they lived long enough. 10, 11 In our study 16(35.6%) patients became hypothyroid after therapy. Hypothyroidism that occurs in the first year following radioactive iodine therapy is related to dose, while the subsequent occurrence is due to a combination of radiation-mediated injury and underlying autoimmunity. 12 Hence current practice guidelines, recommend large single dose because attempting to achieve permanent euthyroidism with radioactive iodine is nearly impossible. 13, 14 Though due to small sample size with short follow up period which preclude any firm conclusion of long term effects of radioiodine therapy. In our observation hyperthyroidism was controlled with single dose of 1-131 in most of the cases as an effective means of treatment with change of essentially unavoidable hypothyroidism. Further long term research is needed in this regard.
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